148 related articles for article (PubMed ID: 23142516)
1. Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease.
Michael R; Rosandić J; Montenegro GA; Lobato E; Tresserra F; Barraquer RI; Vrensen GF
Exp Eye Res; 2013 Jan; 106():5-13. PubMed ID: 23142516
[TBL] [Abstract][Full Text] [Related]
2. Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study.
Michael R; Otto C; Lenferink A; Gelpi E; Montenegro GA; Rosandić J; Tresserra F; Barraquer RI; Vrensen GF
Exp Eye Res; 2014 Feb; 119():44-53. PubMed ID: 24333259
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.
Goldstein LE; Muffat JA; Cherny RA; Moir RD; Ericsson MH; Huang X; Mavros C; Coccia JA; Faget KY; Fitch KA; Masters CL; Tanzi RE; Chylack LT; Bush AI
Lancet; 2003 Apr; 361(9365):1258-65. PubMed ID: 12699953
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
6. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
Jeynes B; Provias J
Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
[TBL] [Abstract][Full Text] [Related]
7. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
8. Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits.
van Duinen SG; Maat-Schieman ML; Bruijn JA; Haan J; Roos RA
Lab Invest; 1995 Aug; 73(2):183-9. PubMed ID: 7637318
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
10. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
Ikeda S; Allsop D; Glenner GG
Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: implications for cortical cataract formation.
Sachdev NH; Di Girolamo N; Nolan TM; McCluskey PJ; Wakefield D; Coroneo MT
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4075-82. PubMed ID: 15505058
[TBL] [Abstract][Full Text] [Related]
12. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
13. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
14. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
15. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy.
Clifford PM; Siu G; Kosciuk M; Levin EC; Venkataraman V; D'Andrea MR; Nagele RG
Brain Res; 2008 Oct; 1234():158-71. PubMed ID: 18708033
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
[TBL] [Abstract][Full Text] [Related]
17. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain.
Wilcock DM; Gordon MN; Morgan D
Nat Protoc; 2006; 1(3):1591-5. PubMed ID: 17406451
[TBL] [Abstract][Full Text] [Related]
18. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
Czasch S; Paul S; Baumgärtner W
Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
[TBL] [Abstract][Full Text] [Related]
19. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.
Preston SD; Steart PV; Wilkinson A; Nicoll JA; Weller RO
Neuropathol Appl Neurobiol; 2003 Apr; 29(2):106-17. PubMed ID: 12662319
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
